Published 31-Oct-2016 by Ashley Kovas, Regulatory Intelligence, Thomson Reuters The Markets in Financial Instruments Directive (MiFID) II’s regime for the funding of investment research by investment firms has proved controversial. It is however important to consider the full range of …
Click here to read the rest of this entry